Giant Biogene IPO: A Collagen Queen, or Saggy-Skinned Stepsister?
The fast-growing skin-care products maker has filed for a Hong Kong listing that could value it at about $8.5 billion Key Takeaways: Giant Biogene has filed for a Hong Kong…
RELATED ARTICLES
-
Saint Bella births Hong Kong IPO, in race to nurture a postpartum empire
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
-
Rebounding RLX plots course beyond China
RLX.US
- Butong navigates twin challenges of falling birthrates, weak consumption
- Breton eyes big haul from investors with Hong Kong IPO plan
